Engerix-B (hepatitis B vaccine recombinant) / GSK  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

2 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Engerix-B (hepatitis B vaccine recombinant) / GSK
PROTECT, NCT05200338: Preservation and Transfer of HBV Immunity After Allogeneic HSCT for SCD

Recruiting
N/A
30
Europe
Engerix-B
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Sickle Cell Disease
01/24
12/24
IRHBRVD, NCT04970836: The Immune Responses After Hepatitis B Revaccination Doses in a Young Cohort

Recruiting
N/A
240
RoW
recombinant hepatitis B vaccine, Engerix-B
National Taiwan University Hospital, Academia Sinica, Taiwan, Ministry of Science and Technology, Taiwan
Hepatitis B, Vaccination; Infection, Preventable Disease, Vaccine
07/24
12/24

Download Options